Explore how 2,5-disubstituted 1,3,4-oxadiazole derivatives are designed as CYP51 inhibitors for antimicrobial activity through molecular docking and ADME prediction.
How clever chemistry is creating smarter, safer 4-Aminopyridyl-based CYP51 inhibitors to combat Chagas disease.